Atlantic Union Bankshares’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$729K Buy
15,203
+176
+1% +$7.56K 0.01% 422
2026
Q1
$552K Buy
15,027
+235
+2% +$11.1K 0.01% 447
2025
Q4
$753K Buy
14,792
+93
+0.6% +$4.76K 0.01% 414
2025
Q3
$816K Buy
14,699
+11,881
+422% +$695K 0.02% 411
2025
Q2
$195K Buy
+2,818
New +$192K ﹤0.01% 479
2014
Q2
Sell
-80
Closed -$7K 195
2014
Q1
$7K Buy
+80
New +$1.7K ﹤0.01% 219

Other funds holding NVO

Atlantic Union Bankshares's NVO Position: Q2 2026 in Review

Atlantic Union Bankshares increased its Novo Nordisk (NVO) stake by 1.2% in Q2 2026, buying an estimated $7.56K and bringing the position to 15,203 shares worth $729K. The position accounts for 0.01% of the portfolio, ranked #422.

Atlantic Union Bankshares first reported a position in NVO in Q1 2014 and has held it in 6 quarters since. The position peaked at $816K in Q3 2025. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Atlantic Union Bankshares held 15,203 shares of Novo Nordisk worth $729K as of Q2 2026.
  • Atlantic Union Bankshares bought 176 Novo Nordisk shares in Q2 2026, an estimated $7.56K.
  • Novo Nordisk made up 0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #422 holding.
  • Atlantic Union Bankshares first reported a position in Novo Nordisk in Q1 2014 and has held it in 6 quarters since.
  • Atlantic Union Bankshares's Novo Nordisk position peaked at $816K in Q3 2025.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.